This blog was created to update friends and family about Ken's battle with Brain Cancer.
Thursday, February 23, 2012
Wednesday, February 22, 2012
Pre-op meeting with surgeon
Today Ken had some pre-op tests, and we met with Dr. Gutin for the first time. He was very confident, and said that he will remove "all visible" tumor. He cannot "get it all",so to speak, because no one can ever guarantee getting every single cell...and all it takes is one cell for the cancer to grow. One of the main purposes of the surgery is to grade the tumor, and test it for genetic/ molecular abnormalities, to determine the course of future treatment. The tumor is small, and close to the surface, so the surgery should not be too difficult. Ken will be put completely under Anesthesia, and the procedure should take approximately 3 hours. They will do some pathology in the O.R., so he will have a good idea of the tumor grade, but will not know definately until the final pathology is done. At this time it appears that the surgery has been postponed to March 6, but we will know for sure tomorrow.
Surgery may be postponed...
The surgery may be postponed...they are still searching for Kenny's brain. Just kidding, scheduling conflict! :)
Friday, February 17, 2012
Thursday, February 16, 2012
February 15, 2012
Dr. M. called...after meeting with the Tumor Board, Radiation Oncologist, and the Surgeon, he feels that surgery is the best option at this time. We were able to get the surgeon that we requested, Dr. Philip Gutin, who is the Chief of Neurosurgery at Memorial Sloan-Kettering. I am thrilled that he has agreed to take on Ken's case. It is my understanding that Dr.Gutin feels that he will be able to remove the entire tumor. Opting for surgery has many advantages over the clinical trial. If Ken were to participate in the trial, he would need to remain on the Avastin permanently, thereby making him ineligible for other therapies. Having the surgery will not only remove the tumor itself (always the best option!) but also allow them to test for Molecular abnormalities and to grade the tumor. Thankfully, Dr. M. feels that the tumor is a grade III, but it is still possible that it is a grade IV,and the only way to know is to take it out. I inquired about the genetic mutation IDH1, and he responded that while there is no medication available at this time, they would test the tumor for the genetic mutation so when a targeted therapy does become available, we will know if Ken qualifies. When the previous surgery was performed three years ago, they didn't even know to test for these things yet. Such advances have been made in so short of a time! So having the surgery (and not being on Avastin) could potentially open the door for future treatments for Ken.
As scary as brain surgery is, we do feel that it is the best option at this time, and, while not a cure, could "reset the clock" on Ken's cancer. I also truly feel that with Dr. Gutin we are in the very best possible hands.
As scary as brain surgery is, we do feel that it is the best option at this time, and, while not a cure, could "reset the clock" on Ken's cancer. I also truly feel that with Dr. Gutin we are in the very best possible hands.
February 10, 2012
Ken had his first MRI since beginning chemotherapy. The tumor has grown, slightly. It was approximately 1.4 centimeters on January 13, and now is 1.9 centimeters. Dr. M. feels that this warrants further action than the Temodar. The fact that the tumor has grown means that it is likely a more aggressive tumor than the original one. Worst case scenario is that the new tumor is a grade IV. The options include surgery, but he feels that they may not be able to get the entire tumor out without affecting Ken's motor function; however, the decision lies with the surgeon himself. The second option is to enroll in a clinical trial at Sloan-Kettering. The trial would be a combination of a very focal radiation therapy, combined with the drug Avastin. It is thought that the Avastin increases the oxygen flow to the area being radiated, therefore making the radiation more effective. He says he has seen some success with this, and there is a trial opening on February 16. The trial involves Avastin via IV Infusion once, then again in two weeks, followed by three doses of radiation. In reading the trial materials, it seems that following radiation he would be on the Avastin indefinately (perhaps the rest of his life?). Dr. M. needs to present the case again at Tumor Board, then meet with the Surgeon, and the radiation oncologist. Then we will come up with a plan.
Chemotherapy
Ken completed his first course of chemotherapy from January 24 through January 28. The dosage is by weight, so being such a big guy, I think he is on a pretty high dose. In any event, the chemo made him pretty sick, and he spend a good deal of time in bed. He seemed worse in the mornings, so he usually was up and about in the afternoons. Poor guy.
Subscribe to:
Posts (Atom)